相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dynamic Contrast-Enhanced Magnetic Resonance Imaging for Assessment of Antiangiogenic Treatment Effects in Multiple Myeloma
Maximilian Merz et al.
CLINICAL CANCER RESEARCH (2015)
The application of Gadopentate-Dimeneglumin has no impact on progression free and overall survival as well as renal function in patients with monoclonal plasma cell disorders if general precautions are taken
J. Hillengass et al.
EUROPEAN RADIOLOGY (2015)
Infiltration patterns in monoclonal plasma cell disorders: correlation of magnetic resonance imaging with matched bone marrow histology
Mindaugas Andrulis et al.
EUROPEAN JOURNAL OF RADIOLOGY (2014)
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
S. Vincent Rajkumar et al.
LANCET ONCOLOGY (2014)
Bone marrow angiogenesis in myeloma and its precursor disease: a prospective clinical trial
M. Bhutani et al.
LEUKEMIA (2014)
Prognostic significance of whole-body MRI in patients with monoclonal gammopathy of undetermined significance
J. Hillengass et al.
LEUKEMIA (2014)
The prognostic importance of the presence of more than one focal lesion in spine MRI of patients with asymptomatic (smoldering) multiple myeloma
E. Kastritis et al.
LEUKEMIA (2014)
Smoldering multiple myeloma requiring treatment: time for a new definition?
Angela Dispenzieri et al.
BLOOD (2013)
Value of whole body MRI and dynamic contrast enhanced MRI in the diagnosis, follow-up and evaluation of disease activity and extent in multiple myeloma
Julie C. Dutoit et al.
EUROPEAN JOURNAL OF RADIOLOGY (2013)
Lenalidomide plus Dexamethasone for High-Risk Smoldering Multiple Myeloma
Maria-Victoria Mateos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Prognostic relevance of 18-F FDG PET/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation
Elena Zamagni et al.
BLOOD (2011)
Lenalidomide Restrains Motility and Overangiogenic Potential of Bone Marrow Endothelial Cells in Patients with Active Multiple Myeloma
Annunziata De Luisi et al.
CLINICAL CANCER RESEARCH (2011)
Emerging Therapies Targeting Tumor Vasculature in Multiple Myeloma and other Hematologic and Solid Malignancies
K. Podar et al.
CURRENT CANCER DRUG TARGETS (2011)
Simulation-based comparison of two approaches frequently used for dynamic contrast-enhanced MRI
Stefan Zwick et al.
EUROPEAN RADIOLOGY (2010)
Prognostic Significance of Focal Lesions in Whole-Body Magnetic Resonance Imaging in Patients With Asymptomatic Multiple Myeloma
Jens Hillengass et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management
R. A. Kyle et al.
LEUKEMIA (2010)
Diffuse MRI marrow pattern correlates with increased angiogenesis, advanced disease features and poor prognosis in newly diagnosed myeloma treated with novel agents
L. A. Moulopoulos et al.
LEUKEMIA (2010)
Multiple Myeloma Treatment Response Assessment with Whole-Body Dynamic Contrast-enhanced MR Imaging
Chieh Lin et al.
RADIOLOGY (2010)
Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study
Ola Landgren et al.
BLOOD (2009)
F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma
Twyla B. Bartel et al.
BLOOD (2009)
Dynamic Contrast-Enhanced Magnetic Resonance Imaging Identifies a Subgroup of Patients with Asymptomatic Monoclonal Plasma Cell Disease and Pathologic Microcirculation
Jens Hillengass et al.
CLINICAL CANCER RESEARCH (2009)
Multiple Myeloma and Monoclonal Gammopathy of Undetermined Significance: Importance of Whole-Body versus Spinal MR Imaging
Tobias Baeuerle et al.
RADIOLOGY (2009)
Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma
Angela Dispenzieri et al.
BLOOD (2008)
Gain of 1q21 and distinct adverse cytogenetic abnormalities correlate with increased microcirculation in multiple myeloma
Jens Hillengass et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
New criteria to identify risk of progression in monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based on multiparameter flow cytometry analysis of bone marrow plasma cells
Ernesto Perez-Persona et al.
BLOOD (2007)
Magnetic resonance imaging in multiple myeloma: Diagnostic and clinical implications
Ronald Walker et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Lumbar bone marrow microcirculation measurements from dynamic contrast-enhanced magnetic resonance imaging is a predictor of event-free survival in progressive multiple myeloma
Jens Hillengass et al.
CLINICAL CANCER RESEARCH (2007)
A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma
Elena Zamagni et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2007)
Prognostic significance of magnetic resonance imaging of bone marrow in previously untreated patients with multiple myeloma
LA Moulopoulos et al.
ANNALS OF ONCOLOGY (2005)
Dynamic contrast-enhanced MRI for assessing the disease activity of multiple myeloma:: A comparative study with histology and clinical markers
S Nosàs-Garcia et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2005)
Orally administered lenalidomide (CC-5013) is anti-angiogenic in vivo and inhibits endothelial cell migration and Akt phosphorylation in vitro
K Dredge et al.
MICROVASCULAR RESEARCH (2005)
Bone marrow angiogenic ability and expression of angiogenic cytokines in myeloma: evidence favoring loss of marrow angiogenesis inhibitory activity with disease progression
S Kumar et al.
BLOOD (2004)
Angiogenesis and anti-angiogenesis in hematological malignancies
D Ribatti et al.
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH (2003)
分享论文
